NCT03582124View on ClinicalTrials.gov

Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 19, 2018

Primary Completion Date

January 31, 2026

Study Completion Date

February 28, 2027

Conditions
Lung CarcinomaMetastatic Malignant Neoplasm in the LungStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Lung Cancer AJCC v8
Interventions
PROCEDURE

Near-Infrared Fluorescence Imaging

Undergo imaging

DRUG

Panitumumab-IRDye800

Given IV

OTHER

Pharmacokinetic Study

Correlative studies

PROCEDURE

Therapeutic Conventional Surgery

Undergo surgery

Trial Locations (1)

94304

RECRUITING

Stanford University, School of Medicine, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER